• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过定量结构-渗透性研究预测药物的渗透性。

Prediction of the permeability of drugs through study on quantitative structure-permeability relationship.

作者信息

Jung Seo Jeong, Choi Sun Ok, Um So Young, Kim Joo Il, Choo Hae Young Park, Choi Su Young, Chung Soo Youn

机构信息

Division of Biopharmaceutics, Department of Pharmacology, National Institute of Toxicological Research, Korea Food and Drug Administration, #231 Jinheungno, Eunpyung-Gu, Seoul, Republic of Korea.

出版信息

J Pharm Biomed Anal. 2006 May 3;41(2):469-75. doi: 10.1016/j.jpba.2005.12.020. Epub 2006 Feb 3.

DOI:10.1016/j.jpba.2005.12.020
PMID:16460901
Abstract

This study is to research the quantitative structure-permeability relationship of 20 drugs having similar structure. Permeability was determined by using the Caco-2 cell in vitro model. The apparent permeability coefficient (Papp) of each drug both of apical to basolateral side and basolateral to apical side was measured at the concentration corresponding to 0.1 times the highest dose strength of 250 mL dissolved buffer. In order to test the permeability system suitability, we measured the Papp of 19 model drugs out of 20 which presented in 'Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms based on the Biopharmaceutics Classification System' of FDA guidance. Also, we demonstrated the functional expression of efflux systems (e.g., p-gp) by bi-directional transport studies with rhodamine 123. Also, as a result of the study on quantitative structure-permeability relationship by using the partial least square method, it was possible to predict the permeability of drugs from their 3D structure. The quantitative structure-permeability relationship provided a cross-validated q2=0.789, a normal r2=0.998. Considering all of above results, analysis on this quantitative structure-permeability relationship appears to be a very useful tool to predict the permeability.

摘要

本研究旨在探讨20种结构相似药物的定量构效关系。采用Caco-2细胞体外模型测定通透性。在对应于250 mL溶解缓冲液中最高剂量强度0.1倍的浓度下,测量每种药物从顶侧向基底侧以及从基底侧向顶侧的表观渗透系数(Papp)。为了测试渗透系统的适用性,我们测量了FDA指南中“基于生物药剂学分类系统的速释固体口服制剂体内生物利用度和生物等效性研究的豁免”中列出的20种模型药物中的19种的Papp。此外,我们通过用罗丹明123进行双向转运研究,证明了外排系统(如p-gp)的功能表达。而且,作为使用偏最小二乘法进行定量构效关系研究的结果,可以从药物的三维结构预测其通透性。定量构效关系提供了交叉验证的q2 = 0.789,常规r2 = 0.998。考虑到上述所有结果,对这种定量构效关系的分析似乎是预测通透性的非常有用的工具。

相似文献

1
Prediction of the permeability of drugs through study on quantitative structure-permeability relationship.通过定量结构-渗透性研究预测药物的渗透性。
J Pharm Biomed Anal. 2006 May 3;41(2):469-75. doi: 10.1016/j.jpba.2005.12.020. Epub 2006 Feb 3.
2
A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture.一种基于新拓扑描述符的模型,用于预测药物在Caco-2细胞培养中的肠道上皮转运。
J Pharm Pharm Sci. 2004 Jun 29;7(2):186-99.
3
Biopharmaceutics classification system: validation and learnings of an in vitro permeability assay.生物药剂学分类系统:体外通透性试验的验证与经验总结
Mol Pharm. 2009 Jan-Feb;6(1):11-8. doi: 10.1021/mp800122b.
4
The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.用于渗透性测定的原位灌注模型的适用性:对BCS I类生物豁免申请的效用
Mol Pharm. 2006 Nov-Dec;3(6):686-94. doi: 10.1021/mp060042f.
5
A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay.一种基于细胞的联合方法,可在单一检测中鉴定P-糖蛋白底物和抑制剂。
Int J Pharm. 2005 Sep 14;301(1-2):80-8. doi: 10.1016/j.ijpharm.2005.05.034.
6
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.佐米曲普坦在人肠上皮细胞系Caco-2中的转运特性
J Pharm Pharmacol. 2007 May;59(5):655-60. doi: 10.1211/jpp.59.5.0005.
7
Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.脂质辅料Peceol和Gelucire 44/14部分地降低了P-糖蛋白介导的罗丹明123外排,这是由于它们改变了Caco-2细胞内P-糖蛋白的蛋白表达。
J Pharm Pharm Sci. 2007;10(3):319-31.
8
Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).使用吸收-处置模型从Caco-2通透性估算人体药物口服吸收动力学:模型开发、评估以及ka和Fa的解析解推导
J Pharmacol Exp Ther. 2005 Jul;314(1):391-9. doi: 10.1124/jpet.104.076182. Epub 2005 Apr 15.
9
Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.不同药物与人工膜的结构和高通量筛选通透性之间的关系:在预测Caco-2细胞通透性中的应用
Bioorg Med Chem. 2005 Aug 1;13(15):4721-32. doi: 10.1016/j.bmc.2005.04.076.
10
Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.肽类药物口服吸收的体外和体内模型的相关性
Amino Acids. 2008 Jun;35(1):233-41. doi: 10.1007/s00726-007-0581-5. Epub 2007 Aug 30.

引用本文的文献

1
Improving the Accuracy of Permeability Data to Gain Predictive Power: Assessing Sources of Variability in Assays Using Cell Monolayers.提高渗透率数据的准确性以获得预测能力:评估使用细胞单层进行的实验中的变异性来源。
Membranes (Basel). 2024 Jul 14;14(7):157. doi: 10.3390/membranes14070157.
2
Metformin-Mediated Improvement in Solubility, Stability, and Permeability of Nonsteroidal Anti-Inflammatory Drugs.二甲双胍介导的非甾体抗炎药溶解性、稳定性及渗透性的改善
Pharmaceutics. 2024 Mar 11;16(3):382. doi: 10.3390/pharmaceutics16030382.
3
New In Vitro Coculture Model for Evaluating Intestinal Absorption of Different Lipid Nanocapsules.
用于评估不同脂质纳米囊泡肠道吸收的新型体外共培养模型
Pharmaceutics. 2021 Apr 21;13(5):595. doi: 10.3390/pharmaceutics13050595.
4
Inspired by the human placenta: a novel 3D bioprinted membrane system to create barrier models.受人类胎盘启发:一种新型的 3D 生物打印膜系统,用于创建屏障模型。
Sci Rep. 2020 Sep 24;10(1):15606. doi: 10.1038/s41598-020-72559-6.
5
Validation of an Ex Vivo Permeation Method for the Intestinal Permeability of Different BCS Drugs and Its Correlation with Caco-2 In Vitro Experiments.不同生物药剂学分类系统(BCS)药物肠道通透性的体外渗透方法验证及其与Caco-2体外实验的相关性
Pharmaceutics. 2019 Nov 29;11(12):638. doi: 10.3390/pharmaceutics11120638.
6
Chemo-Enzymatic Synthesis, Structural and Stereochemical Characterization, and Intrinsic Degradation Kinetics of Diastereomers of 1-β--Acyl Glucuronides Derived from Racemic 2-{4-[(2-Methylprop-2-en-1-yl)amino]phenyl}propanoic Acid.外消旋2-{4-[(2-甲基丙-2-烯-1-基)氨基]苯基}丙酸衍生的1-β-酰基葡糖醛酸非对映异构体的化学酶法合成、结构和立体化学表征以及固有降解动力学
ACS Omega. 2018 May 4;3(5):4932-4940. doi: 10.1021/acsomega.8b00443. eCollection 2018 May 31.
7
An ADME and Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives.新型抗结核药地考喹酯衍生物的吸收、分布、代谢和排泄及药代动力学研究
Front Pharmacol. 2019 Feb 18;10:120. doi: 10.3389/fphar.2019.00120. eCollection 2019.
8
Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.灌注微血管平台中阿霉素转运的实时成像与定量分析
Integr Biol (Camb). 2016 Sep 12;8(9):976-84. doi: 10.1039/c6ib00082g. Epub 2016 Aug 15.
9
Evaluation of the intestinal transport of a phenylethanoid glycoside-rich extract from Cistanche deserticola across the Caco-2 cell monolayer model.肉苁蓉富含苯乙醇苷提取物经Caco-2细胞单层模型的肠道转运评价。
PLoS One. 2015 Feb 3;10(2):e0116490. doi: 10.1371/journal.pone.0116490. eCollection 2015.
10
Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.药物发现和监管方面的考虑因素,以提高使用 Caco-2 作为人体肠道通透性测量替代物的计算和体外预测的准确性。
AAPS J. 2013 Apr;15(2):483-97. doi: 10.1208/s12248-013-9456-8. Epub 2013 Jan 24.